1,109
24
Essay, 1 pages (200 words)

Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins

Advertising We'll write a high-quality original custom paper on Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins just for you with a 15% discount for the 1st order Use a Discount Use a Discount

A corrigendum on

In the original article, there was an error [wrong description on LY3164530 (Eli Lilly) antibody in the last paragraph of page 9 of original article].

A correction has been made to section “ HETERODIMERIC Fc-BASED ANTIBODIES IN DIVERSE FORMATS”, subsection “ Intact IgG Formats with Correct LC Association”, sixth Paragraph (line 8–12 of the sixth paragraph) (In the last paragraph of page 9 of original article):

An alternative approach for enforcing correct HC VH-CH1 –LC association includes introduction of a set of mutations at the heterodimeric VL–CL and VH–CH1 interface (18, 66, 67), similar to modification of the CH3 interface for the heterodimeric Fc design. In an ortho-Fab IgG approach (18), structure-based regional design introduced complementary mutations at the LC and HC VH-CH1 interface in only one Fab, without any changes being made to the other Fab (Figure 3). Zymeworks is currently developing intact IgG-format bsAbs generated by the combination of ortho-Fab IgG and ZW1 Fc technologies ().

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Thank's for Your Vote!
Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins. Page 1
Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins. Page 2
Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins. Page 3

This work, titled "Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins" was written and willingly shared by a fellow student. This sample can be utilized as a research and reference resource to aid in the writing of your own work. Any use of the work that does not include an appropriate citation is banned.

If you are the owner of this work and don’t want it to be published on AssignBuster, request its removal.

Request Removal

Cite this Essay

References

AssignBuster. (2021) 'Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins'. 31 December.

Reference

AssignBuster. (2021, December 31). Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins. Retrieved from https://assignbuster.com/corrigendum-immunoglobulin-fc-heterodimer-platform-technology-from-design-to-applications-in-therapeutic-antibodies-and-proteins/

References

AssignBuster. 2021. "Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins." December 31, 2021. https://assignbuster.com/corrigendum-immunoglobulin-fc-heterodimer-platform-technology-from-design-to-applications-in-therapeutic-antibodies-and-proteins/.

1. AssignBuster. "Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins." December 31, 2021. https://assignbuster.com/corrigendum-immunoglobulin-fc-heterodimer-platform-technology-from-design-to-applications-in-therapeutic-antibodies-and-proteins/.


Bibliography


AssignBuster. "Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins." December 31, 2021. https://assignbuster.com/corrigendum-immunoglobulin-fc-heterodimer-platform-technology-from-design-to-applications-in-therapeutic-antibodies-and-proteins/.

Work Cited

"Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins." AssignBuster, 31 Dec. 2021, assignbuster.com/corrigendum-immunoglobulin-fc-heterodimer-platform-technology-from-design-to-applications-in-therapeutic-antibodies-and-proteins/.

Get in Touch

Please, let us know if you have any ideas on improving Corrigendum: immunoglobulin fc heterodimer platform technology: from design to applications in therapeutic antibodies and proteins, or our service. We will be happy to hear what you think: [email protected]